Dapagliflozin reduces the risks of death and cardiovascular events in patients with heart failure regardless of ejection fraction, according to late breaking research presented in a Hot Line session on 27 August at ESC Congress ...
Aug 29, 2022
0
12
Sacubitril/valsartan does not change cognitive function, compared with valsartan, in patients with heart failure and mildly reduced or preserved ejection fraction, according to late breaking research presented in a Hot Line ...
Aug 26, 2022
0
22
Researchers from RCSI University of Medicine and Health Sciences have developed a new lab-based model of a heart and circulatory system that will help test devices to treat patients with one of the most common forms of heart ...
Jul 26, 2022
0
2
Restricting salt intake is considered a key component of heart failure treatment, but restricting it too much may actually worsen the outcomes for people with a common form of the condition, suggests research published online ...
Jul 18, 2022
0
75
Dapagliflozin reduces the risk for worsening heart failure or cardiovascular death, regardless of frailty status, according to a study published online April 26 in the Annals of Internal Medicine.
Apr 26, 2022
0
2
A new study finds that a history of infertility is associated with increased risk of heart failure. Published in the Journal of the American College of Cardiology, researchers from Massachusetts General Hospital (MGH) revealed ...
Apr 18, 2022
0
23
Heart images may help to predict the risk of sudden cardiac death in heart attack survivors, according to the largest analysis of cardiac magnetic resonance (CMR) data to date. The late breaking research from the PROFID project ...
Apr 4, 2022
0
6
Physicians prescribed significantly more guideline-directed medications for heart failure if they received a customized digital alert via an electronic health record (EHR) system when inputting medical orders shortly after ...
Apr 4, 2022
0
47
Patients with heart failure with reduced ejection fraction (HFrEF) did not experience any improvement in their ability to exercise vigorously after taking the experimental heart failure drug omecamtiv mecarbil, in a study ...
Apr 4, 2022
0
26
A new joint guideline published today from the American College of Cardiology, the American Heart Association, and the Heart Failure Society of America, increases the focus on preventing heart failure (HF) in people who are ...
Apr 1, 2022
0
6
